ENDOGENX
Endogenx is a global pharmaceutical and drug development company based in the United States.
ENDOGENX
Industry:
Health Care Medical
Founded:
2008-01-01
Address:
Los Gatos, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
1.36 M USD
Similar Organizations
Mezzion
Mezzion is a pharmaceuticals company that develops and discovers medicines.
Current Employees Featured
Founder
More informations about "ENDOGENX"
About Us - Endogenex
Prior to joining the team, Stacey was the Chief Commercial Officer at Butterfly Network, leading planning, organization, sales and marketing. She has also held positions as President of …See details»
ENDOGENX - Crunchbase Company Profile & Funding
Organization. ENDOGENX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Endogenx is a global pharmaceutical and drug …See details»
Endogenex - LinkedIn
Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). Endogenex’s innovations focus on resetting the body’s metabolic ...See details»
Endogenx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Endogenx, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:ENDG-6010, ENDG-3010, ENDG-8010, ENDG-4010, Sovateltide. ... The statistics for …See details»
Endogenex – Help Control Type 2 Diabetes – Bringing New Energy …
Transforming treatment options for people living with type 2 diabetes. Endogenex, in partnership with Mayo Clinic, was founded to revolutionize the therapeutic approach to type 2 diabetes (T2D).See details»
Endogenex 2025 Company Profile: Valuation, Funding …
Endogenex General Information Description. Developer of a novel endoscopic procedure designed to treat diabetes. The company offers a medical device that provides patients with a way to regain control of their blood glucose levels, …See details»
Endogenex - Crunchbase Company Profile & Funding
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to …See details»
Endogenex™ Appoints Medical Device Executive, Stacey Pugh, …
Mar 23, 2023 In this role Stacey will lead the organization as it expands its clinical initiatives evaluating the novel ReCETâ„¢ Procedure for the treatment of Type 2 Diabetes. “We are …See details»
Endogenx, Inc.:Company Profile & Technical Research,Competitor …
Nov 11, 2022 Endogenx Inc is a company that provides Drug development, Health care and more. Endogenx Inc is headquartered in United States California. Endogenx Inc was founded …See details»
endogenX Company Profile | Management and Employees List
The value of these therapies will be demonstrated through clinical trials conducted by EndogenX. As major pharmaceutical companies seek to augment their product pipelines and replace …See details»
ENDOGENX - Funding, Financials, Valuation & Investors
Endogenx is a global pharmaceutical and drug development company based in the United States.See details»
Endogenexâ„¢ Appoints Christopher Sorli as Chief Medical Officer
May 18, 2023 "We are honored to have Dr. Sorli join the Endogenex team and bring his expertise of patient care, clinical research, and leadership to our organization," said Stacey …See details»
ENDOGENX - Contacts, Employees, Board Members, Advisors
Endogenx is a global pharmaceutical and drug development company based in the United States.See details»
ENDG-8010 - Drug Targets, Indications, Patents - Synapse
ENDG-8010, Initially developed by Endogenx, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Nervous System Diseases. ... Originator Organization. Endogenx, Inc. …See details»
ReCET Treatment by Endogenex
Signaling a new era in type 2 diabetes therapy. Research shows that signaling from the small intestine (specifically the duodenum) is a key regulator of metabolic function, including blood …See details»
Endogenexâ„¢ Appoints Christopher Sorli as Chief Medical Officer
May 18, 2023 Bringing expertise in diabetes management medical and regulatory affairs, clinical research, and market access Endogenex, Inc., a clinical stage medi...See details»
Clinical Providers - Endogenex
Rethinking the duodenum’s role as a therapeutic target. There is a critical, yet often overlooked, opportunity to bring about positive therapeutic changes in the metabolic system of individuals …See details»
Endogenexâ„¢ Appoints Christopher Sorli as Chief Medical Officer
May 18, 2023 Bringing expertise in diabetes management medical and regulatory affairs, clinical research, and market access. Minneapolis, MN. May 18, 2023 – Endogenex, Inc., a clinical …See details»
Endogenexâ„¢ Appoints Krissy Wright as Chief Financial Officer
Bringing finance, operational, and corporate development expertise to an experienced leadership team. Minneapolis, MN. January 8, 2025 – Endogenex, Inc., a clinical-stage medical device …See details»
ENDOGENX - Crunchbase
Endogenx is a global pharmaceutical and drug development company based in the United States.See details»